Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AVRO

AVROBIO (AVRO)

AVROBIO Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AVRO
DateTimeSourceHeadlineSymbolCompany
02/27/202410:50AMPR Newswire (US)Kuehn Law Encourages CHRD, AVRO, KAMN, and CTLT Investors to Contact Law FirmNASDAQ:AVROAVROBIO Inc
02/23/20244:00PMEdgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AVROAVROBIO Inc
02/05/20248:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVROAVROBIO Inc
02/05/20247:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVROAVROBIO Inc
02/05/20247:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVROAVROBIO Inc
02/05/20247:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVROAVROBIO Inc
02/01/20242:25PMPR Newswire (US)Kuehn Law Encourages ICVX, CSTR, AVRO, and CALB Investors to Contact Law FirmNASDAQ:AVROAVROBIO Inc
01/30/20244:47PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:AVROAVROBIO Inc
01/30/20244:07PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:AVROAVROBIO Inc
01/30/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVROAVROBIO Inc
01/30/20249:05AMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:AVROAVROBIO Inc
01/30/20248:39AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVROAVROBIO Inc
01/30/20248:00AMBusiness WireAVROBIO and Tectonic Therapeutic Announce MergerNASDAQ:AVROAVROBIO Inc
11/09/20234:30PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVROAVROBIO Inc
11/03/20234:15PMEdgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:AVROAVROBIO Inc
08/10/20234:32PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVROAVROBIO Inc
07/12/20237:13AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVROAVROBIO Inc
07/12/20237:00AMBusiness WireAVROBIO to Explore Strategic AlternativesNASDAQ:AVROAVROBIO Inc
07/03/20231:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVROAVROBIO Inc
06/14/20235:20PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:AVROAVROBIO Inc
06/12/20237:20AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVROAVROBIO Inc
06/12/20237:00AMBusiness WireAVROBIO Completes Sale of Cystinosis Gene Therapy Program for $87.5 MillionNASDAQ:AVROAVROBIO Inc
06/09/20234:12PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVROAVROBIO Inc
06/08/20234:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVROAVROBIO Inc
06/08/20234:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVROAVROBIO Inc
06/08/20234:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVROAVROBIO Inc
06/08/20234:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVROAVROBIO Inc
06/08/20234:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVROAVROBIO Inc
06/07/202312:07PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:AVROAVROBIO Inc
06/05/20234:25PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:AVROAVROBIO Inc
 Showing the most relevant articles for your search:NASDAQ:AVRO